NEVVI Medicare utilization intelligence

← back

KALLAKURY, BHASKAR NPI 1245239771 Clinician

Pathology · WASHINGTON, DC

Specialty Pathology — from billed Medicare claims
In practice about 44 years since medical school (class of 1982, self-reported to CMS)
Location WASHINGTON, DC · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 20 codes billed · 2,806 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
MEDSTAR MEDICAL GROUP II LLC
2024–2026
MGMC LLC
2019–2023

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-04

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
88305 Pathology examination of tissue using a microscope, intermediate complexity
88313 Special stained specimen slides to examine tissue including interpretation and report
88341 Special stained specimen slides to examine tissue, each additional procedure
88350 Antibody evaluation, each additional single antibody stain procedure
88307 Pathology examination of tissue using a microscope, moderately high complexity
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers
88311 Preparation of tissue for examination by removing any calcium present
88342 Special stained specimen slides to examine tissue, initial procedure
85097 Bone marrow, smear interpretation
88304 Pathology examination of tissue using a microscope, moderately low complexity
G0452 Molecular pathology procedure; physician interpretation and report
88346 Antibody evaluation, initial single antibody stain procedure
88331 Pathology examination of specimen during surgery, first tissue block
88321 Surgical pathology consultation and report on referred slides prepared elsewhere
88329 Pathology examination of specimen during surgery
88360 Microscopic genetic analysis of tumor, manual
85060 Blood smear interpretation by physician with written report
88309 Pathology examination of tissue using a microscope, high complexity
88348 Electron microscopy for diagnosis
88108 Cell examination of specimen, concentration technique

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.